Artelo Biosciences (ARTL) News Today $4.78 +0.12 (+2.58%) As of 11:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARTL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Artelo Biosciences Announces Closing of $2.0 Million Public OfferingOctober 1, 2025 | globenewswire.comArtelo Biosciences Announces Pricing of $2.0 Million Public OfferingSeptember 30, 2025 | globenewswire.comArtelo Biosciences files to sell common stock, no amount givenSeptember 29, 2025 | msn.comArtelo Biosciences, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded WarrantsSeptember 29, 2025 | quiverquant.comQArtelo Biosciences Announces Proposed Underwritten Public OfferingSeptember 29, 2025 | globenewswire.comArtelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society ConferenceSeptember 29, 2025 | globenewswire.comArtelo Biosciences, Inc. (NASDAQ:ARTL) Receives Average Recommendation of "Buy" from AnalystsSeptember 28, 2025 | americanbankingnews.comArtelo Biosciences Completes Stock Offering with Over-AllotmentSeptember 15, 2025 | tipranks.comArtelo Biosciences Updates Bylaws on September 9, 2025September 10, 2025 | tipranks.comArtelo Biosciences Publishes Promising Preclinical Data on ART12.11, Innovative CBD:TMP Cocrystal for Anxiety and Depression TreatmentSeptember 10, 2025 | quiverquant.comQArtelo Biosciences Closes $3 Million Public Offering of Common Stock and Pre-Funded WarrantsSeptember 5, 2025 | quiverquant.comQArtelo Biosciences Announces Closing of $3.0 Million Public OfferingSeptember 5, 2025 | globenewswire.comArtelo prices 640,924 shares at $4.40 in underwritten public offeringSeptember 4, 2025 | msn.comArtelo Biosciences Announces Pricing of $3.0 Million Public OfferingSeptember 4, 2025 | globenewswire.comArtelo Biosciences Announces Proposed Underwritten Public OfferingSeptember 3, 2025 | globenewswire.comArtelo does not envision need to internally fund Phase 3 trial of ART27.13September 3, 2025 | msn.comArtelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS ResultsSeptember 3, 2025 | globenewswire.comArtelo Biosciences Reports Encouraging Interim Results for ART27.13 in Phase 2 Cancer Appetite Recovery Study, Supporting Weight Gain and Activity Improvements in Cancer PatientsSeptember 3, 2025 | quiverquant.comQArtelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)September 3, 2025 | globenewswire.comArtelo Biosciences announces data on food effect evaluation with ART26.12August 25, 2025 | msn.comArtelo Biosciences Reports Positive Safety and Pharmacokinetic Results for ART26.12, Advancing to Multiple Ascending Dose TrialAugust 25, 2025 | quiverquant.comQArtelo Biosciences Announces New Data from an Initial Food Effect Investigation with ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent PainAugust 25, 2025 | globenewswire.comArtelo Biosciences Ends Securities Purchase AgreementAugust 20, 2025 | tipranks.comArtelo Biosciences Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 13, 2025 | tmcnet.comArtelo Biosciences Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 13, 2025 | globenewswire.comArtelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13August 11, 2025 | globenewswire.comArtelo Biosciences stock soars after announcing $9.5M private placement for Solana-based treasuryAugust 4, 2025 | investing.comArtelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve AssetAugust 4, 2025 | globenewswire.comArtelo Biosciences stock surges after receiving favorable UK regulatory guidanceAugust 1, 2025 | investing.comArtelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company's Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and DepressionAugust 1, 2025 | globenewswire.comArtelo Biosciences completes reverse stock split and reports ...July 13, 2025 | investing.comArtelo Biosciences Presents Preclinical Data on ART26.12 as ... - NasdaqJuly 11, 2025 | nasdaq.comARTL - Artelo Biosciences Inc Financials | MorningstarJuly 11, 2025 | morningstar.comMArtelo Biosciences stock soars after positive preclinical pain dataJuly 10, 2025 | investing.comArtelo Biosciences’ ART12.11 Shows Promising Antidepressant Effects in Preclinical StudyJuly 10, 2025 | msn.comArtelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society SymposiumJuly 9, 2025 | globenewswire.comArtelo Biosciences, Inc. Common Stock (ARTL) - NasdaqJuly 8, 2025 | nasdaq.comD. Boral Capital Upgrades Artelo Biosciences (ARTL)July 8, 2025 | msn.comArtelo Biosciences Stock Climbs on Positive Preclinical Efficacy for Depression Drug CandidateJuly 8, 2025 | marketwatch.comArtelo Biosciences Stock Soars 114% After Promising Depression Treatment DataJuly 8, 2025 | msn.comArtelo Biosciences Stock Soars On Strong Preclinical Data In Par With Zoloft For Experimental Depression DrugJuly 8, 2025 | msn.comArtelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression ModelJuly 7, 2025 | globenewswire.comARTL - Artelo Biosciences Inc Sustainability - MorningstarJuly 2, 2025 | morningstar.comMArtelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain - Seeking AlphaJuly 2, 2025 | seekingalpha.comArtelo Biosciences Inc. (ARTL) Stock Price Today - WSJJune 30, 2025 | wsj.comArtelo Biosciences Stock Rises on Positive Trial Data for Treatment for Persistent PainJune 30, 2025 | marketwatch.comArtelo Biosciences stock soars after positive first-in-human study resultsJune 30, 2025 | za.investing.comArtelo Biosciences Stock Doubles After Positive Results In First Non-Opioid Pain Treatment TrialJune 30, 2025 | msn.comArtelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent PainJune 30, 2025 | globenewswire.comArtelo Biosciences, Inc. (ARTL) - Yahoo FinanceJune 26, 2025 | finance.yahoo.com Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARTL Media Mentions By Week ARTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARTL News Sentiment▼0.000.63▲Average Medical News Sentiment ARTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARTL Articles This Week▼11▲ARTL Articles Average Week Get the Latest News and Ratings for ARTL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Artelo Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Cocrystal Pharma News TherapeuticsMD News Silexion Therapeutics News Mustang Bio News Gelteq News HOOKIPA Pharma News Aptorum Group News IM Cannabis News KALA BIO News LakeShore Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARTL) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
